INHIBITEX, INC. (INHX) [Rocket]

In millions, except per share items	Sep-30-11	Jun-30-11	Mar-31-11	Dec-31-10	Sep-30-10	Jun-30-10	Mar-31-10	Dec-31-09
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Net income	-5.3	-5.3	-7.5	-7.0	-5.3	-5.6	-4.8	-4.7
Depreciation and amortization	0.1	0.1	0.2	0.2	0.2	0.2	0.2	0.2
Stock-based compensation	0.3	0.3	0.5	0.5	0.1	0.1	0.1	0.1
Change in working capital [+]	0.4	-3.1	1.2	0.6	-0.2	0.8	0.1	-0.1
Accounts receivable	0.0	0.0	0.1	-0.1	0.0	0.1	-0.1	0.0
Other current assets	-0.4	-0.4			0.1	0.2
Accounts payable	0.2	-0.5			-0.7	0.6
Accrued expenses	0.5	-0.9			0.7	-0.1
Deferred revenues	0.0	-0.1			-0.3	0.2
Other		-1.2	1.2	0.7		-0.1	0.1	-0.2
Other operating activities	0.2	1.0	-0.8	1.1	0.1	-0.6	0.9	0.1
Cash from operations	-4.3	-7.0	-6.4	-4.7	-5.1	-5.1	-3.5	-4.5

Capital expenditures	0.0	-0.1	0.0	0.0	0.0	0.0	0.0	-0.1
Purchases of property and equipment	0.0	-0.1		0.0	0.0		0.0	-0.1
Purchases of short-term investments, net	3.3	-30.4		17.7	7.2	6.2	-2.3	15.3
Purchases of short-term investments	-13.6	-41.4		17.7	-6.1	-9.3	-2.3	15.3
Sales of short-term investments	16.9	11.0			13.3	15.5
Other cash from investing		-8.0	8.0	-13.6		-3.3	3.3	-29.1
Cash from investing	3.3	-38.4	8.0	4.0	7.2	3.0	0.9	-13.9

Issuance of common stock, net		50.8	0.0	0.2		0.0	0.0	0.0
Option exercises	0.4	1.6			0.1	0.5
Other cash from financing	0.7	2.9	-0.1	-0.1	0.2	1.0	-0.1	21.4
Cash from financing	0.3	52.1	-0.1	0.1	0.1	0.5	-0.1	21.4

Free cash flow	-4.3	-7.0	-6.4	-4.7	-5.1	-5.1	-3.5	-4.5
Per share (diluted)	($0.05)	($0.09)	($0.10)	($0.08)	($0.08)	($0.08)	($0.06)	($0.10)

Cash paid for interest	0.0	0.0			0.0	0.0